Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Diabetes

Free Subscription Articles published in Invest Ophthalmol Vis Sci Retrieve available abstracts of 124 articles: HTML format

Single Articles

October 2026
1. OWUSU-AFRIYIE B, Wu CS, Kafle R, Burhans L, et al
   Multimodal Retinal Structural and Functional Tests Identify Local and Layer-Related Alterations in Early Type 2 Diabetes.
   Invest Ophthalmol Vis Sci. 2026;67:3.
   PubMed     Abstract available
   
   
   
2. SALOBRAR-GARCIA E, Opazo-Rios L, Matamoros JA, Sanchez-Puebla L, et al
   Neuroprotective and Anti-Inflammatory Effects of SOCS1 Mimetic Peptides in Mouse Diabetic Retinopathy.
   Invest Ophthalmol Vis Sci. 2026;67:21.
   PubMed     Abstract available
   
   
   
3. LI H, Long J, Dai S, Han W, et al
   Targeting Endoplasmic Reticulum Stress With Exogenous GDNF Promotes Diabetic Corneal Epithelial and Neural Repair via PI3K/AKT Signaling.
   Invest Ophthalmol Vis Sci. 2026;67:24.
   PubMed     Abstract available
   
   
   
4. LEE SY, Kim DE, Kim A, Kim H, et al
   Macrophage-Associated Profibrotic Programs in Diabetic Epiretinal Membrane and Their Modulation by Faricimab.
   Invest Ophthalmol Vis Sci. 2026;67:51.
   PubMed     Abstract available
   
   
   
5. ALMEIDA AC, Pais M, Pinto I, Reste-Ferreira D, et al
   Retinal Microvascular and Neuronal Alterations in Type 2 Diabetes: Insights From a Population-Based Screening Program (START2).
   Invest Ophthalmol Vis Sci. 2026;67:61.
   PubMed     Abstract available
   
   
   September 2026
6. HUA X, Hormel TT, Wang J, Flaxel CJ, et al
   Structural and Angiographic Assessment of the Nerve Fiber Layer in Age-Related Macular Degeneration and Diabetic Retinopathy.
   Invest Ophthalmol Vis Sci. 2026;67:17.
   PubMed     Abstract available
   
   
   
7. SHAH J, Niktinat H, Kakihara S, Fawzi AA, et al
   Outer Retinal Volume on Macular OCT Predicts Two-Year Diabetic Retinopathy Progression.
   Invest Ophthalmol Vis Sci. 2026;67:35.
   PubMed     Abstract available
   
   
   
8. LIU Q, Liu Y, Yang X, Liu T, et al
   Integrated Multi-Tissue Omics Identifies Acylcarnitine Accumulation as Shared Metabolic Marker of Diabetic Microangiopathy With Cross-Organ Validation.
   Invest Ophthalmol Vis Sci. 2026;67:31.
   PubMed     Abstract available
   
   
   
9. MIDENA E, Lupidi M, Frizziero L, Midena G, et al
   The Behavior of the External Limiting Membrane and Ellipsoid Zone in Diabetic Macular Edema: A Population AI-Assisted Optical Coherence Tomography Study.
   Invest Ophthalmol Vis Sci. 2026;67:40.
   PubMed     Abstract available
   
   
   
10. SUN H, Zhou L, Luo T, Li C, et al
    L-Threonic Acid Inhibits Pathological Retinal Neovascularization by Modulation of CCL3-CCR5 Signaling Pathway.
    Invest Ophthalmol Vis Sci. 2026;67:51.
    PubMed     Abstract available
    
    
    
11. LIU X, Lin H, Shao Y, Shen J, et al
    Study on the Regulatory Mechanism of GLP-1 Receptor Agonist Liraglutide in Diabetic Corneal Epithelial Wound Healing.
    Invest Ophthalmol Vis Sci. 2026;67:52.
    PubMed     Abstract available
    
    
    August 2026
12. LARSEN PP, Linard M, Schweitzer C, Delyfer MN, et al
    Exploring Endotoxemia in Age-Related Macular Degeneration, Glaucoma, and Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2026;67:14.
    PubMed     Abstract available
    
    
    
13. ZHENG F, Hong Y, Chua J, Foo SH, et al
    Macular Choriocapillaris and Retinal Microvascular Alterations Across the Prediabetes-Early Type 2 Diabetes Continuum.
    Invest Ophthalmol Vis Sci. 2026;67:16.
    PubMed     Abstract available
    
    
    
14. DA SILVA RA, Ferreira LPS, Roda VMP, Dos Santos DD, et al
    Annexin A1 as a Key Modulator of Inflammatory, Glial, and Angiogenic Signaling Pathways in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2026;67:12.
    PubMed     Abstract available
    
    
    
15. HUANG Z, Jian L, Xiang J, Du Y, et al
    Triglyceride-Glucose-Related Indexes as Risk Factors for Vision-Threatening Ocular Diseases: A Prospective UK Biobank Study.
    Invest Ophthalmol Vis Sci. 2026;67:48.
    PubMed     Abstract available
    
    
    July 2026
16. QAMBARI H, Hein M, Yu PK, Yu DY, et al
    Degeneration of Interpericyte Tunneling Nanotubes Can Occur in the Absence of Pericyte Loss in Diabetic Retina Disease.
    Invest Ophthalmol Vis Sci. 2026;67:1.
    PubMed     Abstract available
    
    
    
17. LI N, Liu L, Sun W, Liu D, et al
    Whole-Exome Analysis Identifies Candidate Genes Associated With Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2026;67:25.
    PubMed     Abstract available
    
    
    
18. ZONG Y, Fan Q, Qiu S, Zhang H, et al
    The Molecular Basis of Ocular Aging: Mechanisms, Pathologies, and Emerging Therapeutics.
    Invest Ophthalmol Vis Sci. 2026;67:13.
    PubMed     Abstract available
    
    
    
19. ZAIDI SAH, Lemtalsi T, Xu Z, Yamamoto M, et al
    Novel Role of AcylCoA: Cholesterol Acyltransferase 1/Sterol O-Acyltransferase 1 (ACAT1/SOAT1) in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2026;67:52.
    PubMed     Abstract available
    
    
    
20. CHLAN E, Li C, Bales KL, Wood LB, et al
    L-DOPA Promotes Post-Treatment Neurovascular and Synaptic Homeostasis in Early Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2026;67:42.
    PubMed     Abstract available
    
    
    June 2026
21. YU J, Gao YL, Zhang Y, Xu JM, et al
    Associations of Multiomics Biological Aging With Diabetic Retinopathy and Life Expectancy.
    Invest Ophthalmol Vis Sci. 2026;67:36.
    PubMed     Abstract available
    
    
    
22. GUO Z, Li X, Chen X, Ma X, et al
    Senp1 O-GlcNAcylation Promotes Mitochondrial Fragmentation by Regulating Fis1 SUMO1-ylation Underlying Diabetic Cataract.
    Invest Ophthalmol Vis Sci. 2026;67:44.
    PubMed     Abstract available
    
    
    May 2026
23. TORM MEW, Johannesen J, Gardner TW, Hajari JN, et al
    Retinal Neurophysiological Parameters in Young Patients With Type 1 Diabetes.
    Invest Ophthalmol Vis Sci. 2026;67:3.
    PubMed     Abstract available
    
    
    
24. HUANG Y, Gui M, Kong X, Li T, et al
    Longitudinal Multi-Omics Profiling of Aqueous Humor Implicates GALNS Depletion as a Pro-Fibrotic Mediator of Anti-VEGF Therapy in PDR.
    Invest Ophthalmol Vis Sci. 2026;67:43.
    PubMed     Abstract available
    
    
    
25. GAO N, Yu FX
    Role of Programmed Cell Death Pathways in Mediating Epithelial Wound Healing and Its Defects in Diabetic Corneas.
    Invest Ophthalmol Vis Sci. 2026;67:75.
    PubMed     Abstract available
    
    
    
26. SEAH WH, Song W, Zhuang L, Loh TY, et al
    Evaluation of Vascular Biomarkers in Diabetic Retinopathy Using Ultrawide-Field Swept-Source Optical Coherence Tomography Angiography: The DRIVE Study.
    Invest Ophthalmol Vis Sci. 2026;67:65.
    PubMed     Abstract available
    
    
    April 2026
27. HERNANDEZ KR, Pollock LM, Rodriguez AD, Lohr MF, et al
    Insulin Induces Outer Blood-Retinal Barrier Disruption via Downregulation of Claudin-19.
    Invest Ophthalmol Vis Sci. 2026;67:39.
    PubMed     Abstract available
    
    
    
28. PARK JC, Cross A, McAnany JJ
    Rod Pathway Dysfunction in Early-Stage Diabetic Retinopathy Assessed by ERG and Pupillometry.
    Invest Ophthalmol Vis Sci. 2026;67:53.
    PubMed     Abstract available
    
    
    
29. LI X, Luo L, Chen S, Sun Y, et al
    PANK4 Regulates YAP to Modulate the Glycolytic Pathway in LEC for Driving LECs-EMT in Early Diabetic Cataract Pathogenesis.
    Invest Ophthalmol Vis Sci. 2026;67:66.
    PubMed     Abstract available
    
    
    March 2026
30. CHEN TR, Zhou JX, Hou YR, Zhang YN, et al
    Neddylation-Mediated hnRNPA2B1 Degradation Aggravates Retinal Endothelial Cell Dysfunction in Diabetic Retinopathy by Regulating miR-93-5p/VEGFA.
    Invest Ophthalmol Vis Sci. 2026;67:5.
    PubMed     Abstract available
    
    
    February 2026
31. LESSIEUR EM, Saadane A, Du Y, Kiser J, et al
    Theophylline Inhibits Capillary Degeneration in Early Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2026;67:8.
    PubMed     Abstract available
    
    
    
32. KREBS AK, Diaz D, Sassani JW, Zagon IS, et al
    Mitigation of Oxidative Stress Pathways in the Diabetic Cornea and Lacrimal Glands Contributes to the Rapid Reversal of Diabetic Dry Eye by Naltrexone.
    Invest Ophthalmol Vis Sci. 2026;67:23.
    PubMed     Abstract available
    
    
    
33. YU Y, Zhang Y, Tang Y, Ma L, et al
    Advanced Glycation End-Products Contribute to Delayed Diabetic Corneal Epithelial Wound Healing via the TLR4 Signaling.
    Invest Ophthalmol Vis Sci. 2026;67:40.
    PubMed     Abstract available
    
    
    
34. HUANG L, Liang W, Huma T, Clayton JM, et al
    Ferroptosis: A Novel Mechanism in Diabetic Keratopathy.
    Invest Ophthalmol Vis Sci. 2026;67:41.
    PubMed     Abstract available
    
    
    January 2026
35. ZHANG B, Sun Y, Jiang X, Hu Z, et al
    METTL16 Inhibits Lens Epithelial Cells Function in Diabetic Cataract via m6A-Modified DKK1-Mediated Wnt/beta-Catenin Signaling.
    Invest Ophthalmol Vis Sci. 2026;67:1.
    PubMed     Abstract available
    
    
    
36. LV K, Peng J, Wang H, Li Y, et al
    Olink Proteomic Profiling of Vitreous Humor and Plasma From Proliferative Diabetic Retinopathy Patients Identifies a Novel Inflammatory Molecular Endotype.
    Invest Ophthalmol Vis Sci. 2026;67:47.
    PubMed     Abstract available
    
    
    
37. BUSZA AM, Kakihara S, Zhuang K, Yamaguchi TC, et al
    Baseline Nonperfusion and Deep Capillary Plexus Ischemia Predict Two-Year Retinal Nonperfusion Progression in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2026;67:64.
    PubMed     Abstract available
    
    
    
38. WANG E, Feng B, Chen S, Wang H, et al
    Silencing of lncRNA HOTAIR Using Eyedrops as a Potential Treatment for Diabetes-Associated Retinal Dysregulation and Dysfunction.
    Invest Ophthalmol Vis Sci. 2026;67:24.
    PubMed     Abstract available
    
    
    December 2025
39. KAKIHARA S, Zhuang K, Busza A, Fawzi AA, et al
    Macular Microaneurysms Are Associated With Chronic Kidney Disease and Deep Capillary Plexus Ischemia in Referable Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2025;66:3.
    PubMed     Abstract available
    
    
    
40. HU W, Yang H, Zhu Q, Zheng G, et al
    KLF10-IN-1 Attenuates RPE Cell Apoptosis and Experimental Diabetic Retinopathy Via the KLF10/PERK/eIF2alpha/ATF4/CHOP Pathway.
    Invest Ophthalmol Vis Sci. 2025;66:25.
    PubMed     Abstract available
    
    
    
41. YOKOTA H, Hayashi H, Nakagami H, Kushiyama A, et al
    Evidence Supporting Autotaxin as a Potential New Drug Treatment Target in Patients With Advanced Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2025;66:49.
    PubMed     Abstract available
    
    
    
42. LI X, Guo Z, Li C, Zhang S, et al
    Glutaredoxin 2 Protects Lens Epithelial Cells From Ferroptosis by Preventing HNRNPA2B1 S-Glutathionylation in Diabetes-Mediated Cataractogenesis.
    Invest Ophthalmol Vis Sci. 2025;66:58.
    PubMed     Abstract available
    
    
    November 2025
43. 
    Retraction of: VEGF as a Survival Factor in Ex Vivo Models of Early Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2025;66:17.
    PubMed    
    
    
    
44. NAM MH, Nahomi RB, Suk J, Panja S, et al
    DJ-1 Protects Human Retinal Endothelial Cells From Diabetes-Related Conditions and Prevents Ischemic Damage in Mouse Retinal Capillaries.
    Invest Ophthalmol Vis Sci. 2025;66:8.
    PubMed     Abstract available
    
    
    
45. TAN R, Shahidzadeh A, Collazo A, Jiang X, et al
    The Association of Retinal Capillary Density and Retinal Thickness in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2025;66:3.
    PubMed     Abstract available
    
    
    
46. OMAE T, Ono S, Kamiya T, Otani S, et al
    Dipeptidyl Peptidase 4, a Novel Adipokine, Impairs Retinal Microcirculation in Patients With Type 2 Diabetes Mellitus.
    Invest Ophthalmol Vis Sci. 2025;66:4.
    PubMed     Abstract available
    
    
    
47. KAKIHARA S, Zhuang K, Fawzi AA
    Macular Deep Capillary Plexus Ischemia as a Biomarker for Identifying Referable Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2025;66:45.
    PubMed     Abstract available
    
    
    
48. MAO Z, Yang W, Chao Y, Chen Z, et al
    Palmitic Acid Induces Ferroptosis in Retinal Microvascular Endothelial Cells by Palmitoylation of Keap1 to Affect Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2025;66:41.
    PubMed     Abstract available
    
    
    October 2025
49. WANG N, Yao F, Xu W, Feng T, et al
    The Transcription Factor Islet-1 Regulates Diabetes-Induced Inner Blood-Retinal Barrier Disruption.
    Invest Ophthalmol Vis Sci. 2025;66:8.
    PubMed     Abstract available
    
    
    
50. VUORI N, Antikainen AA, Haukka JK, Harjutsalo V, et al
    Exome and Genome Sequencing Reveals Novel Variants for Severe Diabetic Retinopathy in Type 1 Diabetes.
    Invest Ophthalmol Vis Sci. 2025;66:36.
    PubMed     Abstract available
    
    
    
51. SHAH J, Zhuang K, Kakihara S, Fawzi AA, et al
    Understanding How Low Luminance Visual Deficit Progresses With Advancing Diabetic Macular Ischemia and Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2025;66:38.
    PubMed     Abstract available
    
    
    September 2025
52. WANG J, Hormel T, Park DW, Haq S, et al
    Quantifying Choriocapillaris Flow Deficits in Diabetic Retinopathy Using Projection-Resolved OCT Angiography.
    Invest Ophthalmol Vis Sci. 2025;66:13.
    PubMed     Abstract available
    
    
    
53. HE Y, Zhou J, Wang J, Huang S, et al
    Novel Visceral Obesity Indicators and Associated Metabolic Fingerprint in Incident Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2025;66:17.
    PubMed     Abstract available
    
    
    
54. HE Z, Peng X, Feng Y, Li Z, et al
    LINC02099 Promotes Retinal Extracellular Matrix Deposition in Diabetic Mice Via the miRNA-214-3p/CTSS Axis.
    Invest Ophthalmol Vis Sci. 2025;66:42.
    PubMed     Abstract available
    
    
    
55. 
    Erratum in: Comments on "Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema".
    Invest Ophthalmol Vis Sci. 2025;66:64.
    PubMed    
    
    
    August 2025
56. HUANG Z, Chen C, Meng J, Liu S, et al
    Associations Among Sleep Duration, Sleep Quality, and Age-Related Ocular Diseases: Insights From Longitudinal and Mediation Analyses.
    Invest Ophthalmol Vis Sci. 2025;66:15.
    PubMed     Abstract available
    
    
    
57. REN Z, Li Z, Dou S, Zhao H, et al
    Effects of Cholesterol Metabolism on Corneal Endothelial Dysfunction in Patients With Type 1 Diabetes.
    Invest Ophthalmol Vis Sci. 2025;66:9.
    PubMed     Abstract available
    
    
    
58. VON SCHULTHESS EL, Maunz A, Chakravarthy U, Holekamp N, et al
    Author Response: Letter to the Editor Regarding "Intraretinal Hyper-Reflective Foci Are Almost Universally Present and Co-Localize With Intraretinal Fluid in Diabetic Macular Edema".
    Invest Ophthalmol Vis Sci. 2025;66:36.
    PubMed    
    
    
    
59. ZHANG Y, Wang R, Li Y, Zhu W, et al
    Hyperglycemia-Reduced Platelet-Derived Growth Factor-BB Expression Impairs Corneal Wound Healing in Diabetic Mice.
    Invest Ophthalmol Vis Sci. 2025;66:61.
    PubMed     Abstract available
    
    
    
60. HUBER KL, Steiner I, Pollreisz A
    Author Response: Retina Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2025;66:51.
    PubMed    
    
    
    
61. YANG Y, Zhang J
    Comments on "Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema".
    Invest Ophthalmol Vis Sci. 2025;66:52.
    PubMed    
    
    
    
62. KAKIHARA S, Zhuang K, AbdelSalam M, Yamaguchi TC, et al
    The Importance of Matching Optical Coherence Tomography Angiography Metrics to Diabetic Retinopathy Severity for Detecting Progression.
    Invest Ophthalmol Vis Sci. 2025;66:49.
    PubMed     Abstract available
    
    
    
63. UNLU EK, Marx-Rattner R, Klein KA, Dawson VL, et al
    Differential Expression of the Synapse Regulatory Proteins Neurexins in Early Diabetic Retinal Disease.
    Invest Ophthalmol Vis Sci. 2025;66:46.
    PubMed     Abstract available
    
    
    July 2025
64. MITAMURA M, Kase S, Endo H, Saito M, et al
    Diabetes-Induced Dysregulation of Peripapillary and Macular Neurovascular Units.
    Invest Ophthalmol Vis Sci. 2025;66:10.
    PubMed     Abstract available
    
    
    
65. YAN B, Qiu J, Yang Y, Luo J, et al
    Exosomal miRNA Profiling in Liquid Biopsy of Vitreous in Proliferative Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2025;66:24.
    PubMed     Abstract available
    
    
    
66. LI H, Peng H, Ma B, Sun X, et al
    DJ-1 Promotes Diabetic Corneal Epithelial Wound Healing by Attenuating Hyperglycemia-Induced Oxidative Stress Through Inhibiting PTEN.
    Invest Ophthalmol Vis Sci. 2025;66:20.
    PubMed     Abstract available
    
    
    
67. GAO N, Me R, Singh S, Kumar A, et al
    Hyperglycemia-Suppressed Acod1 Expression Contributes to Innate Immune Deficiency in Pseudomonas aeruginosa Keratitis.
    Invest Ophthalmol Vis Sci. 2025;66:51.
    PubMed     Abstract available
    
    
    June 2025
68. QIN X, Sun J, Xu Y, Lu L, et al
    Short-Chain Fatty Acids Are Potential Biomarkers of Immune Regulation in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2025;66:23.
    PubMed     Abstract available
    
    
    
69. ZHAO Y, Dong Y, Zheng Q, Zhao Y, et al
    Fatty Acid Desaturase 1 Knockdown Promotes Wound Healing and Functional Recovery of the Corneal Epithelium in Diabetes.
    Invest Ophthalmol Vis Sci. 2025;66:6.
    PubMed     Abstract available
    
    
    
70. KLAASSEN I, Vader MJC, Aissa K, Tanck MWT, et al
    Several Common Genetic Variations Associate With Functional or Anatomic Effects of Anti-VEGF Treatment in Conditions With Macular Edema.
    Invest Ophthalmol Vis Sci. 2025;66:2.
    PubMed     Abstract available
    
    
    
71. KAKIHARA S, Busza A, Yamaguchi TC, Fawzi AA, et al
    Posterior Retinal Ischemia Correlates With Vision in Patients With Diabetes.
    Invest Ophthalmol Vis Sci. 2025;66:5.
    PubMed     Abstract available
    
    
    
72. WANG J, Yin Z, Yang J, Sun S, et al
    BCAT1 Activation Reprograms Branched-Chain Amino Acid Metabolism and Epigenetically Promotes Inflammation in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2025;66:59.
    PubMed     Abstract available
    
    
    April 2025
73. ONG JX, Lee HJ, Decker NL, Castellanos-Canales D, et al
    Volumetric Measures of Capillary Nonperfusion on Optical Coherence Tomography Angiography Detect Early Ischemia in Diabetes Without Retinopathy.
    Invest Ophthalmol Vis Sci. 2025;66:2.
    PubMed     Abstract available
    
    
    
74. GAO M, Guo Y, Hormel TT, Wang J, et al
    Nonperfused Retinal Capillaries-A New Method Developed on OCT and OCTA.
    Invest Ophthalmol Vis Sci. 2025;66:22.
    PubMed     Abstract available
    
    
    
75. LIN Y, Yang L, Li Y, Dou S, et al
    CD4+CD25- T-Cell-Secreted IFN-gamma Promotes Corneal Nerve Degeneration in Diabetic Mice.
    Invest Ophthalmol Vis Sci. 2025;66:15.
    PubMed     Abstract available
    
    
    
76. XIAO X, Zhao J, Lin S, Yang Y, et al
    Relationships Between Retinal Vascular Characteristics and Systemic Indicators in Patients With Diabetes Mellitus.
    Invest Ophthalmol Vis Sci. 2025;66:72.
    PubMed     Abstract available
    
    
    
77. HA SK, Ding X, Romano F, Overbey KM, et al
    Structure-Function Associations Between Quantitative Contrast Sensitivity Function And Peripapillary Optical Coherence Tomography Angiography in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2025;66:69.
    PubMed     Abstract available
    
    
    
78. PAN SY, Weng CH, Tsai SF, Lin HJ, et al
    Use of SGLT2 Inhibitors Versus DPP-4 Inhibitors and Age-Related Macular Degeneration in Patients WithType 2 Diabetes: A Multinational Cohort Study.
    Invest Ophthalmol Vis Sci. 2025;66:58.
    PubMed     Abstract available
    
    
    March 2025
79. HORMEL TT, Beaulieu WT, Wang J, Sun JK, et al
    Artificial Intelligence Versus Rules-Based Approach for Segmenting NonPerfusion Area in a DRCR Retina Network Optical Coherence Tomography Angiography Dataset.
    Invest Ophthalmol Vis Sci. 2025;66:22.
    PubMed     Abstract available
    
    
    
80. DIAZ D, Sassani JW, Zagon IS, McLaughlin PJ, et al
    Reversal of Diabetic Dry Eye by Topical Opioid Receptor Blockade Follows Dual Pathways.
    Invest Ophthalmol Vis Sci. 2025;66:24.
    PubMed     Abstract available
    
    
    
81. MARMALIDOU A, Siddiqui H, Jamil MU, Woo KM, et al
    Comparison Between MAIA and MP-3 In Healthy Subjects and Patients With Diabetes, Diabetic Retinopathy, and Age-Related Macular Degeneration.
    Invest Ophthalmol Vis Sci. 2025;66:59.
    PubMed     Abstract available
    
    
    
82. GURUNG RL, Nangia C, Cai T, FitzGerald LM, et al
    Genome-Wide Association Study to Identify Genetic Variants Associated With Diabetic Maculopathy.
    Invest Ophthalmol Vis Sci. 2025;66:55.
    PubMed     Abstract available
    
    
    
83. SADEGHI E, Du K, Ajayi O, Davis E, et al
    Three-Dimensional Choroidal Vessels Assessment in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2025;66:50.
    PubMed     Abstract available
    
    
    
84. ALBERTOS-ARRANZ H, Martinez-Gil N, Sanchez-Saez X, Molina-Martin JC, et al
    Neuronal Degeneration and Glial Activation in the Absence of Vascular Changes in Human Retinas of Patients With Diabetes.
    Invest Ophthalmol Vis Sci. 2025;66:53.
    PubMed     Abstract available
    
    
    February 2025
85. ZHOU L, Fan S, Lu H, Zhang W, et al
    Retinal and Choriocapillaris Thickness Changes in Spontaneously Diabetic Macaques.
    Invest Ophthalmol Vis Sci. 2025;66:11.
    PubMed     Abstract available
    
    
    
86. CHANG MC, Lin DP, Chang HH
    Hepatic Satellite Cell Activation and Alteration of Vitamin A Status Are Relevant to the Aggravation of Retinopathy by T2DM.
    Invest Ophthalmol Vis Sci. 2025;66:7.
    PubMed     Abstract available
    
    
    
87. CHEN YY, Yang CM, Yang CH, Ho TC, et al
    Elevated Very-Long-Chain Ceramides in the Vitreous Humor of Patients With Proliferative Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2025;66:28.
    PubMed     Abstract available
    
    
    
88. TANG Z, Yang D, Nguyen TX, Zhang S, et al
    Relationship of OCT-Based Diabetic Retinal Neurodegeneration to the Development and Progression of Diabetic Retinopathy: A Cohort Study.
    Invest Ophthalmol Vis Sci. 2025;66:32.
    PubMed     Abstract available
    
    
    
89. MIDENA E, Frizziero L
    Letter to the Editor Regarding "Intraretinal Hyper-Reflective Foci Are Almost Universally Present and Co-Localize With Intraretinal Fluid in Diabetic Macular Edema".
    Invest Ophthalmol Vis Sci. 2025;66:59.
    PubMed    
    
    
    
90. SHAH R, Amador C, Poe AJ, Spektor TM, et al
    Identification of Wnt-5a Receptors Important in Diabetic and Non-Diabetic Corneal Epithelial Wound Healing.
    Invest Ophthalmol Vis Sci. 2025;66:64.
    PubMed     Abstract available
    
    
    January 2025
91. QIU AW, Wang NY, Yin WJ, Zhu ZQ, et al
    Retinal Muller Cell-Released Exosomal MiR-92a-3p Delivers Interleukin-17A Signal by Targeting Notch-1 to Promote Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2025;66:1.
    PubMed     Abstract available
    
    
    
92. PEI X, Ba M, Yang T, Xuan S, et al
    Leptin Receptor Deficiency-Associated Diabetes Disrupts Lacrimal Gland Circadian Rhythms and Contributes to Dry Eye Syndrome.
    Invest Ophthalmol Vis Sci. 2025;66:19.
    PubMed     Abstract available
    
    
    
93. OLIVEIRA S, Guimaraes P, Campos EJ, Fernandes R, et al
    Retinal OCT-Derived Texture Features as Potential Biomarkers for Early Diagnosis and Progression of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2025;66:7.
    PubMed     Abstract available
    
    
    December 2024
94. VAUGHAN M, Tay N, Kalitzeos A, Kane T, et al
    Changes in Waveguiding Cone Photoreceptors and Color Vision in Patients With Diabetes Mellitus.
    Invest Ophthalmol Vis Sci. 2024;65:28.
    PubMed     Abstract available
    
    
    
95. YANG Y, Fan C, Zhang Y, Kang T, et al
    Untargeted Metabolomics Reveals the Role of Lipocalin-2 in the Pathological Changes of Lens and Retina in Diabetic Mice.
    Invest Ophthalmol Vis Sci. 2024;65:19.
    PubMed     Abstract available
    
    
    
96. LAI C, Su T, Cao J, Li Q, et al
    Retinal Neurovascular Impairment in Full-Course Diabetic Retinopathy: The Guangdong Diabetic Retinopathy Multiple-Omics Study.
    Invest Ophthalmol Vis Sci. 2024;65:20.
    PubMed     Abstract available
    
    
    
97. YU Y, Cui S, He Y, Zhang J, et al
    Early Diabetic Retinopathy Evaluation With OCTA: A Study on Vascular Branching and Fragmentation.
    Invest Ophthalmol Vis Sci. 2024;65:21.
    PubMed     Abstract available
    
    
    
98. SUGASINI D, Yalagala PCR, Park JC, Ma G, et al
    Retinal Docosahexaenoic Acid Is Significantly Reduced in Diabetic Humans and Mice: Possible Relationship to Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2024;65:39.
    PubMed     Abstract available
    
    
    
99. HUBER KL, Stino H, Steiner I, Fuchs P, et al
    Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2024;65:46.
    PubMed     Abstract available
    
    
    November 2024
100. AWAD AM, Seetharaman ATM, Hossain MS, Elshaer SL, et al
     Cysteine Leukotriene Receptor Antagonist-Montelukast Effects on Diabetic Retinal Microvascular Endothelial Cells Curtail Autophagy.
     Invest Ophthalmol Vis Sci. 2024;65:15.
     PubMed     Abstract available
     
     
     
101. YAO X, Li Z, Lei Y, Liu Q, et al
     Single-Cell Multiomics Profiling Reveals Heterogeneity of Muller Cells in the Oxygen-Induced Retinopathy Model.
     Invest Ophthalmol Vis Sci. 2024;65:8.
     PubMed     Abstract available
     
     
     
102. YU Y, Chen H, Wang Z, Ye Y, et al
     Exploring the Relationship Between Refractive Errors and Common Chronic Diseases Via Blood Biochemistry Tests: A Large Prospective Cohort Study.
     Invest Ophthalmol Vis Sci. 2024;65:26.
     PubMed     Abstract available
     
     
     
103. ANTONETTI DA, Lin CM, Shanmugam S, Hager H, et al
     Diabetes Renders Photoreceptors Susceptible to Retinal Ischemia-Reperfusion Injury.
     Invest Ophthalmol Vis Sci. 2024;65:46.
     PubMed     Abstract available
     
     
     
104. MA DJ, Kim SM, Choi JM
     Associations of Retinal Vessel Geometry and Optical Coherence Tomography Angiography Metrics With Choroidal Metrics in Diabetic Retinopathy.
     Invest Ophthalmol Vis Sci. 2024;65:31.
     PubMed     Abstract available
     
     
     
105. SOTANI Y, Imai H, Yamada H, Miki A, et al
     High Intraocular Concentration of Fibrinogen Regulates Retinal Function Via the ICAM-1 Pathway.
     Invest Ophthalmol Vis Sci. 2024;65:34.
     PubMed     Abstract available
     
     
     October 2024
106. ZHONG X, Li H, Tan S, Yang S, et al
     Initial Retinal Nerve Fiber Layer Loss and Risk of Diabetic Retinopathy Over a Four-Year Period.
     Invest Ophthalmol Vis Sci. 2024;65:5.
     PubMed     Abstract available
     
     
     
107. ZHANG W, Wang X, Tian S, Wang J, et al
     Fetuin-B Interacts With Insulin Receptor-beta and Promotes Insulin Resistance in Retina Cells.
     Invest Ophthalmol Vis Sci. 2024;65:16.
     PubMed     Abstract available
     
     
     
108. LU ZL, Zhao Y, Lesmes LA, Dorr M, et al
     Quantifying the Functional Relationship Between Visual Acuity and Contrast Sensitivity Function.
     Invest Ophthalmol Vis Sci. 2024;65:33.
     PubMed     Abstract available
     
     
     September 2024
109. CHOI YJ, Kim HM, Na TY, Park KH, et al
     Intraocular Concentration of Stem Cell Factor/c-KIT and Galectin-1 in Retinal Diseases.
     Invest Ophthalmol Vis Sci. 2024;65:11.
     PubMed     Abstract available
     
     
     
110. DAI Y, Mao S, Zang X, Ge H, et al
     RTP4 Enhances Corneal HSV-1 Infection in Mice With Type 2 Diabetes Mellitus.
     Invest Ophthalmol Vis Sci. 2024;65:36.
     PubMed     Abstract available
     
     
     August 2024
111. BOSCIA G, Bacherini D, Vujosevic S, Grassi MO, et al
     Long-Term Impact of Diabetic Retinopathy on Response to Anti-VEGF Treatment in Neovascular AMD.
     Invest Ophthalmol Vis Sci. 2024;65:6.
     PubMed     Abstract available
     
     
     
112. ABTAHI M, Le D, Ebrahimi B, Dadzie AK, et al
     Differential Capillary and Large Vessel Analysis Improves OCTA Classification of Diabetic Retinopathy.
     Invest Ophthalmol Vis Sci. 2024;65:20.
     PubMed     Abstract available
     
     
     July 2024
113. DING X, Romano F, Garg I, Gan J, et al
     Longitudinal Assessment of Intraretinal Microvascular Abnormalities in Diabetic Retinopathy Using Swept-Source Optical Coherence Tomography Angiography.
     Invest Ophthalmol Vis Sci. 2024;65:29.
     PubMed     Abstract available
     
     
     June 2024
114. STINO H, Huber KL, Kunze L, Steiner I, et al
     Intereye Microvascular Differences in Patients With Same-Stage Diabetic Retinopathy Revealed by OCTA.
     Invest Ophthalmol Vis Sci. 2024;65:11.
     PubMed     Abstract available
     
     
     
115. JIANG K, Zhang F, Chen Y, Li X, et al
     Fosfenopril Attenuates Inflammatory Response in Diabetic Dry Eye Models by Inhibiting the TLR4/NF-kappaB/NLRP3 Signaling Pathway.
     Invest Ophthalmol Vis Sci. 2024;65:2.
     PubMed     Abstract available
     
     
     
116. TSAI HR, Lin YJ, Yeh JI, Lin SM, et al
     Use of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients With Type 2 Diabetes and the Incidence of Retinal Vein Occlusion in Taiwan.
     Invest Ophthalmol Vis Sci. 2024;65:19.
     PubMed     Abstract available
     
     
     May 2024
117. 
     Erratum in: Transthyretin-Regulated Diabetic Retinopathy Through the VEGFA/PI3K/AKT Pathway.
     Invest Ophthalmol Vis Sci. 2024;65:12.
     PubMed    
     
     
     
118. VON SCHULTHESS EL, Maunz A, Chakravarthy U, Holekamp N, et al
     Intraretinal Hyper-Reflective Foci Are Almost Universally Present and Co-Localize With Intraretinal Fluid in Diabetic Macular Edema.
     Invest Ophthalmol Vis Sci. 2024;65:26.
     PubMed     Abstract available
     
     
     April 2024
119. FADAKAR K, Rahmani S, Tedeschi T, Lavine JA, et al
     Short Term Effect of Pre-Operative Anti-VEGF on Angiogenic and Fibrotic Profile of Fibrovascular Membranes of Proliferative Diabetic Retinopathy.
     Invest Ophthalmol Vis Sci. 2024;65:37.
     PubMed     Abstract available
     
     
     March 2024
120. SACHDEVA MM, Lee Y, Unlu EK, Koseoglu ND, et al
     Tandem Mass Tag LC-MS/MS of Aqueous Humor From Individuals With Type 2 Diabetes Without Retinopathy Reveals Early Dysregulation of Synaptic Proteins.
     Invest Ophthalmol Vis Sci. 2024;65:16.
     PubMed     Abstract available
     
     
     
121. QIN S, Ma L, Ferreira F, Brown C, et al
     Diabetic Ocular Surface Has Defects in Oxygen Uptake Revealed by Optic Fiber Microsensor.
     Invest Ophthalmol Vis Sci. 2024;65:27.
     PubMed     Abstract available
     
     
     
122. MOIR J, Hyman MJ, Gonnah R, Flores A, et al
     The Association Between Metformin Use and New-Onset ICD Coding of Geographic Atrophy.
     Invest Ophthalmol Vis Sci. 2024;65:23.
     PubMed     Abstract available
     
     
     
123. MCCURRY CM, Sunilkumar S, Subrahmanian SM, Yerlikaya EI, et al
     NLRP3 Inflammasome Priming in the Retina of Diabetic Mice Requires REDD1-Dependent Activation of GSK3beta.
     Invest Ophthalmol Vis Sci. 2024;65:34.
     PubMed     Abstract available
     
     
     
124. GAO N, Yu FS
     Lack of Elevated Expression of TGFbeta3 Contributes to the Delay of Epithelial Wound Healing in Diabetic Corneas.
     Invest Ophthalmol Vis Sci. 2024;65:35.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum